CL
BMY icon

Choreo LLC’s Bristol-Myers Squibb BMY Stock Holding History

Choreo LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.86M Buy
129,588
+3,504
+3% +$204K 0.1% 157
2025
Q4 		$6.84M Buy
126,084
+1,528
+1% +$73.5K 0.09% 153
2025
Q3 		$5.62M Sell
124,556
-2,070
-2% -$96.7K 0.07% 186
2025
Q2 		$5.86M Sell
126,626
-4,899
-4% -$240K 0.08% 172
2025
Q1 		$8.02M Sell
131,525
-1,693
-1% -$98.7K 0.12% 118
2024
Q4 		$7.52M Sell
133,218
-96,595
-42% -$5.4M 0.11% 133
2024
Q3 		$12.2M Buy
229,813
+112,428
+96% +$5.27M 0.18% 99
2024
Q2 		$4.85M Buy
117,385
+29,100
+33% +$1.3M 0.08% 163
2024
Q1 		$4.79M Sell
88,285
-157
-0.2% -$8K 0.12% 107
2023
Q4 		$4.54M Buy
88,442
+2,492
+3% +$131K 0.12% 110
2023
Q3 		$4.99M Buy
85,950
+1,739
+2% +$107K 0.18% 77
2023
Q2 		$5.39M Sell
84,211
-2,413
-3% -$162K 0.18% 73
2023
Q1 		$6M Buy
86,624
+76,245
+735% +$5.38M 0.21% 73
2022
Q4 		$746K Buy
10,379
+1,649
+19% +$124K 0.04% 117
2022
Q3 		$621K Buy
8,730
+947
+12% +$68.7K 0.04% 112
2022
Q2 		$599K Buy
7,783
+1,340
+21% +$102K 0.03% 117
2022
Q1 		$470K Buy
6,443
+300
+5% +$20.1K 0.02% 146
2021
Q4 		$383K Sell
6,143
-1,345
-18% -$78.9K 0.02% 160
2021
Q3 		$443K Buy
7,488
+264
+4% +$17.4K 0.02% 142
2021
Q2 		$483K Sell
7,224
-55
-0.8% -$3.59K 0.03% 136
2021
Q1 		$459K Sell
7,279
-1,084
-13% -$67.4K 0.03% 126
2020
Q4 		$519K Hold
8,363
– – 0.04% 121
2020
Q3 		$504K Buy
8,363
+199
+2% +$12K 0.04% 117
2020
Q2 		$480K Sell
8,164
-6,600
-45% -$395K 0.05% 117
2020
Q1 		$823K Buy
14,764
+146
+1% +$8.92K 0.1% 79
2019
Q4 		$938K Sell
14,618
-3,524
-19% -$202K 0.09% 89
2019
Q3 		$920K Sell
18,142
-352
-2% -$16.5K 0.11% 85
2019
Q2 		$839K Buy
18,494
+794
+4% +$37K 0.1% 90
2019
Q1 		$844K Sell
17,700
-1,041
-6% -$51.9K 0.1% 89
2018
Q4 		$974K Buy
18,741
+55
+0.3% +$2.96K 0.14% 77
2018
Q3 		$1.16M Sell
18,686
-175
-0.9% -$10.4K 0.15% 77
2018
Q2 		$1.04M Sell
18,861
-2,581
-12% -$139K 0.14% 89
2018
Q1 		$1.36M Sell
21,442
-2,423
-10% -$156K 0.16% 85
2017
Q4 		$1.46M Sell
23,865
-518
-2% -$32.4K 0.18% 74
2017
Q3 		$1.55M Buy
24,383
+1,827
+8% +$107K 0.2% 71
2017
Q2 		$1.26M Sell
22,556
-984
-4% -$53.5K 0.18% 78
2017
Q1 		$1.28M Buy
23,540
+1,264
+6% +$69.3K 0.19% 78
2016
Q4 		$1.3M Buy
22,276
+7,447
+50% +$407K 0.21% 76
2016
Q3 		$800K Buy
14,829
+1,431
+11% +$91.9K 0.14% 90
2016
Q2 		$985K Sell
13,398
-240
-2% -$17K 0.19% 72
2016
Q1 		$876K Buy
13,638
+2,417
+22% +$152K 0.18% 71
2015
Q4 		$776K Buy
11,221
+1,093
+11% +$72.2K 0.18% 65
2015
Q3 		$603K Buy
10,128
+565
+6% +$35.8K 0.16% 69
2015
Q2 		$636K Buy
9,563
+60
+0.6% +$3.95K 0.16% 72
2015
Q1 		$613K Buy
9,503
+666
+8% +$41.7K 0.16% 73
2014
Q4 		$525K Buy
8,837
+781
+10% +$44K 0.14% 77
2014
Q3 		$412K Buy
8,056
+380
+5% +$19K 0.12% 82
2014
Q2 		$372K Sell
7,676
-902
-11% -$44.5K 0.11% 93
2014
Q1 		$446K Buy
+8,578
New +$456K 0.13% 74

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Choreo LLC's BMY Position: Q1 2026 in Review

Choreo LLC increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, buying an estimated $204K and bringing the position to 129,588 shares worth $7.86M. The position accounts for 0.1% of the portfolio, ranked #157.

Choreo LLC first reported a position in BMY in Q1 2014 and has held it in 49 quarters since. The position peaked at $12.2M in Q3 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Choreo LLC held 129,588 shares of Bristol-Myers Squibb worth $7.86M as of Q1 2026.
  • Choreo LLC bought 3,504 Bristol-Myers Squibb shares in Q1 2026, an estimated $204K.
  • Bristol-Myers Squibb made up 0.1% of Choreo LLC's portfolio in Q1 2026, its #157 holding.
  • Choreo LLC first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 49 quarters since.
  • Choreo LLC's Bristol-Myers Squibb position peaked at $12.2M in Q3 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.